학술논문

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
Document Type
article
Source
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Subject
Science
Language
English
ISSN
2041-1723
Abstract
Current SARS-CoV-2 variants evade immune responses induced by approved vaccines. In this study, the authors find that a recombinant prefusion-stabilized Beta spike protein vaccine confers broad neutralization capacity in mice and non-human primates as well as protective antibody and immune memory responses.